紅麴 Red Yeast Rice
B 2 C 1
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場：against
Red yeast rice products that contain more than trace amounts of monacolin K cannot be sold legally as dietary supplements; if a red yeast rice product has enhanced or added lovastatin — which is structurally identical to monacolin K — it is considered an unapproved new drug and cannot be marketed as a dietary supplement.
來源 ↗ L4b · EU EFSA
立場：against
L4c · UK NHS
立場：not_addressed
L4d · TW TFDA / 衛福部
立場：supportive
本標準適用之紅麴產品為利用米進行紅麴菌培養並予乾燥，直接製成粉狀、膠囊或錠狀之食品。……每日攝取量所含之monacolin K至少應達四．八毫克，但不得超過十五毫克。……所含之citrinin含量濃度應低於百萬分之二（2 ppm）。
來源 ↗ L4e · WHO
立場：not_addressed
市場與行銷 (L10)
L10a · TW Market Channels
大研生醫 納豆紅麴Q10膠囊 60粒/盒
L10b · TW Legal Identity (TFDA)
每日攝取量所含之monacolin K至少應達4.8毫克，但不得超過15毫克；所含之citrinin含量濃度應低於百萬分之二
L10c · TW Community (PTT/Dcard/Mobile01)
最有感的是血液循環，今年冬天比較不會手腳冰冷